Induction of chronic human immunodeficiency virus infection is blocked in vitro by a methylphosphonate oligodeoxynucleoside targeted to a U3 enhancer element - PubMed (original) (raw)

Induction of chronic human immunodeficiency virus infection is blocked in vitro by a methylphosphonate oligodeoxynucleoside targeted to a U3 enhancer element

J Laurence et al. J Virol. 1991 Jan.

Abstract

Oligodeoxynucleosides with internucleoside methylphosphonate linkages complementary to regions within U3 of human immunodeficiency virus type 1 were evaluated for their ability to block phorbol myristate acetate upregulation of virus in chronically infected promonocytic and T-lymphoblastoid cell lines. One such oligomer, targeted to an NF-kappa B enhancer element, inhibited phorbol myristate acetate induction of viral replication and tat-mediated trans activation of the human immunodeficiency virus long terminal repeat. The effect of this construct is contrasted with classical antisense methylphosphonate-derivatized oligomers complementary to initiation codon and splice acceptor sites of human immunodeficiency virus structural and regulatory genes. Its activity suggests a novel application of the modified oligonucleotide strategy in the blockade of viral induction from latently infected cells.

PubMed Disclaimer

Cited by

Gene-targeted inhibition of transactivation of human immunodeficiency virus type-1 (HIV-1)-LTR by antisense oligonucleotides.
Demirhan I, Hasselmayer O, Hofmann D, Chandra A, Svinarchuk FP, Vlassov VV, Engels J, Chandra P. Demirhan I, et al. Virus Genes. 1995 Jan;9(2):113-9. doi: 10.1007/BF01702654. Virus Genes. 1995. PMID: 7732657
Stable human immunodeficiency virus type 1 (HIV-1) resistance in transformed CD4+ monocytic cells treated with multitargeting HIV-1 antisense sequences incorporated into U1 snRNA.
Liu D, Donegan J, Nuovo G, Mitra D, Laurence J. Liu D, et al. J Virol. 1997 May;71(5):4079-85. doi: 10.1128/JVI.71.5.4079-4085.1997. J Virol. 1997. PMID: 9094686 Free PMC article.
Protein kinase C-zeta mediates NF-kappa B activation in human immunodeficiency virus-infected monocytes.
Folgueira L, McElhinny JA, Bren GD, MacMorran WS, Diaz-Meco MT, Moscat J, Paya CV. Folgueira L, et al. J Virol. 1996 Jan;70(1):223-31. doi: 10.1128/JVI.70.1.223-231.1996. J Virol. 1996. PMID: 8523529 Free PMC article.
Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element.
Vickers T, Baker BF, Cook PD, Zounes M, Buckheit RW Jr, Germany J, Ecker DJ. Vickers T, et al. Nucleic Acids Res. 1991 Jun 25;19(12):3359-68. doi: 10.1093/nar/19.12.3359. Nucleic Acids Res. 1991. PMID: 2062653 Free PMC article.
Modified antisense oligodeoxynucleotides against the splice acceptor site of tat do not inhibit in vitro hematopoietic colony growth in HIV-positive patients.
Geissler RG, Muth J, Maurer A, Mentzel U, Mag M, Engels JW, Hoelzer D, Ganser A. Geissler RG, et al. Ann Hematol. 1995 Aug;71(2):89-95. doi: 10.1007/BF01699252. Ann Hematol. 1995. PMID: 7544629

References

1. J Virol. 1990 Jun;64(6):2932-40 - PubMed
1. AIDS. 1990 Jun;4(6):559-64 - PubMed
1. Nature. 1990 Jun 14;345(6276):640-2 - PubMed
1. Science. 1990 Apr 13;248(4952):208-12 - PubMed
1. Blood. 1990 Feb 1;75(3):696-703 - PubMed

Induction of chronic human immunodeficiency virus infection is blocked in vitro by a methylphosphonate oligodeoxynucleoside targeted to a U3 enhancer element - PubMed (original) (raw)